Newsmaker: Daniel Johnson
Noteworthy: Johnson received a $1.9 million, five-year grant from the National Institutes of Health to continue studying how gene mutations affect oral squamous cell carcinoma; determining the risk to patients from various therapies; and developing new treatments. About 40,000 cases of the deadly cancer are diagnosed annually in the United States.
Family: Wife, Sylvia; daughter, Rachel; sons, Josiah and Matthew
Occupation: Professor of medicine at the University of Pittsburgh School of Medicine and a senior scientist in the University of Pittsburgh Cancer Institute Head and Neck Cancer Program
Education: Ph.D. and master's degree from Princeton University; bachelor's degree in chemistry from North Park College in Chicago; post-doctoral fellowship at the University of California San Francisco
Quote: “Efforts to combat OSCC have been severely hindered by an incomplete understanding of the mechanisms of disease progression and a lack of molecular markers that can be used to predict responsiveness to chemotherapy and radiation. These studies will seek to improve the efficacies of radiation in chemotherapy in patients with head and neck cancer.”